# Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate

> **NCT01329991** · PHASE1 · COMPLETED · sponsor: **Plexxikon** · enrollment: 26 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** PLX5622
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01329991
- **Lead sponsor:** Plexxikon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01329991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01329991, "Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01329991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*